Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis. Aspects of a Protein Quality Disease

Journal of the American College of Cardiology

Volumn 51, Issue 21, 2008, Pages 2003-2010

  Herrmann, Joerg ^a   Soares, Sandra M ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHAPERONE; PROTEASOME; UBIQUITIN;

ATHEROSCLEROSIS; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN QUALITY; REVIEW; VASCULAR DISEASE;

ATHEROSCLEROSIS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN FOLDING; UBIQUITIN; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 43549098451     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.02.047     Document Type: Review

References (50)

1. Bukau B., Weissman J., and Horwich A. Molecular chaperones and protein quality control. Cell 125 (2006) 443-451
2. Herrmann J., Lerman L.O., and Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ Res 100 (2007) 1276-1291
3. Wickner S., Maurizi M.R., and Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 286 (1999) 1888-1893
4. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 (2007) 519-529
5. Bernales S., McDonald K.L., and Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 4 (2006) e423
6. Carrell R.W., and Lomas D.A. Conformational disease. Lancet 350 (1997) 134-138
7. Taylor J.P., Hardy J., and Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science 296 (2002) 1991-1995
8. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl (2004) S10-S17
9. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 (2004) 1055-1063
10. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
11. LaFerla F.M., Green K.N., and Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8 (2007) 499-509
12. Bucciantini M., Giannoni E., Chiti F., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
13. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478
14. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., and Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 142 (1993) 1927-1937
15. Berberian P.A., Myers W., Tytell M., Challa V., and Bond M.G. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol 136 (1990) 71-80
16. Kanwar R.K., Kanwar J.R., Wang D., Ormrod D.J., and Krissansen G.W. Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21 (2001) 1991-1997
17. Herrmann J., Edwards W.D., Holmes Jr. D.R., et al. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol 40 (2002) 1919-1927
18. Marfella R., D'Amico M., Di Filippo C., et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol 47 (2006) 2444-2455
19. Versari D., Herrmann J., Gossl M., et al. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol 26 (2006) 2132-2139
20. Herrmann J., Gulati R., Napoli C., et al. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J 17 (2003) 1730-1732
21. Tan C., Li Y., Tan X., Pan H., and Huang W. Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis. Clin Chem Lab Med 44 (2006) 1218-1225
22. Herrmann J., Saguner A.M., Versari D., et al. Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res 101 (2007) 865-874
23. Xu J., Wu Y., Song P., Zhang M., Wang S., and Zou M.H. Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116 (2007) 944-953
24. Zhou J., Lhotak S., Hilditch B.A., and Austin R.C. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111 (2005) 1814-1821
25. Feng B., Yao P.M., Li Y., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5 (2003) 781-792
26. Dickhout J.G., Hossain G.S., Pozza L.M., Zhou J., Lhotak S., and Austin R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 2623-2629
27. Gargalovic P.S., Gharavi N.M., Clark M.J., et al. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 26 (2006) 2490-2496
28. Horke S., Witte I., Wilgenbus P., Kruger M., Strand D., and Forstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115 (2007) 2055-2064
29. Johnson A.D., Berberian P.A., Tytell M., and Bond M.G. Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler Thromb Vasc Biol 15 (1995) 27-36
30. Meiners S., Laule M., Rother W., et al. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 105 (2002) 483-489
31. Stangl V., Lorenz M., Meiners S., et al. Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. Faseb J 18 (2004) 272-279
32. Vieira O., Escargueil-Blanc I., Jurgens G., et al. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J 14 (2000) 532-542
33. Mucchiano G.I., Haggqvist B., Sletten K., and Westermark P. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 193 (2001) 270-275
34. Rocken C., Tautenhahn J., Buhling F., et al. Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler Thromb Vasc Biol 26 (2006) 676-677
35. Ursini F., Davies K.J., Maiorino M., Parasassi T., and Sevanian A. Atherosclerosis: another protein misfolding disease?. Trends Mol Med 8 (2002) 370-374
36. Stewart C.R., Tseng A.A., Mok Y.F., et al. Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry 44 (2005) 9108-9116
37. Howlett G.J., and Moore K.J. Untangling the role of amyloid in atherosclerosis. Curr Opin Lipidol 17 (2006) 541-547
38. Medeiros L.A., Khan T., El Khoury J.B., et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem 279 (2004) 10643-10648
39. Beckmann N., Schuler A., Mueggler T., et al. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23 (2003) 8453-8459
40. Elesber A.A., Bonetti P.O., Woodrum J.E., et al. Bosentan preserves endothelial function in mice overexpressing APP. Neurobiol Aging 27 (2006) 446-450
41. Suo Z., Humphrey J., Kundtz A., et al. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 257 (1998) 77-80
42. Gentile M.T., Vecchione C., Maffei A., et al. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem 279 (2004) 48135-48142
43. Thomas T., McLendon C., Sutton E.T., and Thomas G. Cerebrovascular endothelial dysfunction mediated by beta-amyloid. Neuroreport 8 (1997) 1387-1391
44. Thomas T., Sutton E.T., Bryant M.W., and Rhodin J.A. In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid. J Submicrosc Cytol Pathol 29 (1997) 293-304
45. Revesz T., Ghiso J., Lashley T., et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62 (2003) 885-898
46. Li L., Cao D., Garber D.W., Kim H., and Fukuchi K. Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am J Pathol 163 (2003) 2155-2164
47. Wang X., and Robbins J. Heart failure and protein quality control. Circ Res 99 (2006) 1315-1328
48. Patterson C., Ike C., Willis P.Wt., Stouffer G.A., and Willis M.S. The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 115 (2007) 1456-1463
49. Trifilo M.J., Yajima T., Gu Y., et al. Prion-induced amyloid heart disease with high blood infectivity in transgenic mice. Science 313 (2006) 94-97
50. Chesebro B., Trifilo M., Race R., et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439